SCHEMBL6566617

SCHEMBL6566617

CCN(Cc1ccncc1)C(=O)c1cc(NC(=O)Nc2ccccc2)ccc1OC(c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.47
LMNA P02545 5/20 0.45
MAPT P10636 4/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
TSHR P16473 2/20 0.45
POLB P06746 1/20 0.45
RAB9A P51151 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM4 P08173 1/20 0.45
CHRM5 P08912 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
BLM P54132 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
NFKB1 P19838 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567858 0.85 LIMK2 (0.44) MEN1KMT2A
SCHEMBL6567978 0.84 MEN1 (0.45) MAPK1MAPTMEN1KMT2APOLB
SCHEMBL6566546 0.84 PDE4A (0.48) MAPK1LMNAMAPTMEN1KMT2A
SCHEMBL6566966 0.83 TP53 (0.43) LMNAMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6566485 0.82 NAMPT (0.44) LMNAMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6566976 0.82 NAMPT (0.44) LMNAMAPTMEN1KMT2AGAA
SCHEMBL6566811 0.80 NPC1 (0.43) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL6567749 0.80 HTT (0.54) MAPTMEN1KMT2APOLBRAB9A
SCHEMBL6567930 0.79 MEN1 (0.43) LMNAMEN1KMT2ASMN1; SMN2NAMPT
SCHEMBL6566515 0.79 NAMPT (0.52) LMNAMAPTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MAPK1 1934/4885LMNA 4043/4885MAPT 4743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.